These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5315095)

  • 21. [Rifampicin in pulmonary tuberculosis: clinico-radiologic and humoral findings].
    Scarpazza G; Garimoldi M; Cirianni C; Perna G
    G Ital Mal Torace; 1968; 22(5):255-61. PubMed ID: 5704058
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anatomo-bacteriological criteria of the effect of rifampicin in the treatment of pulmonary tuberculosis].
    Morère P; Stain JP; Hubert J; Chauvet MC
    Rev Tuberc Pneumol (Paris); 1970; 34(5):714. PubMed ID: 5496794
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience with the use of rifampicin (rimactan) in patients with chronic destructive forms of pulmonary tuberculosis].
    Ginzburg ZI
    Probl Tuberk; 1971; 49(12):77-8. PubMed ID: 5145746
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)].
    Urakami E; Nagasawa S
    Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413
    [No Abstract]   [Full Text] [Related]  

  • 25. Rifampicin in the treatment of drug-resistant tuberculosis. A report on 13 patients with pulmonary and one patient with renal disease.
    Engbaek HC; Vergmann B
    Scand J Respir Dis; 1970; 51(1):11-27. PubMed ID: 5456856
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and radiological results of rifampicin therapy in chronic pulmonary tuberculosis].
    Merenda P
    G Ital Mal Torace; 1969; ():Suppl 2:105-6. PubMed ID: 5357132
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 1. A preliminary study. The results of Rifampicin treatment for advanced pulmonary tuberculosis resistant to conventional antituberculous drugs].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):251-6. PubMed ID: 5460317
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of rifampicin in venous perfusion in a group of patients with pulmonary tuberculosis].
    Bettini L; Fossati C
    Clin Ter; 1976 Nov; 79(3):263-72. PubMed ID: 1017171
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 31. [Humoral and bacteriological findings in patients with pulmonary tuberculosis during rifampicin therapy].
    Stringa C
    G Ital Mal Torace; 1969; ():Suppl 2:107-8. PubMed ID: 5357133
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical observations on the use of Rifampicin].
    Filograna V
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):477-80. PubMed ID: 5309061
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 35. Rifampicin in the treatment of chronic pulmonary tuberculosis. Investigations on clinical activity and side effects.
    Pickroth G; Anschel R; Kalich R; Kandt D
    Acta Tuberc Pneumol Belg; 1969; 60(3):513-8. PubMed ID: 5371676
    [No Abstract]   [Full Text] [Related]  

  • 36. Rifampicin in the treatment of pulmonary tuberculosis.
    Nitti V
    Bull Int Union Tuberc; 1970 Jun; 43():57-9. PubMed ID: 5425575
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of pulmonary tuberculosis with rifampicin].
    Baroni V
    G Ital Mal Torace; 1969; ():Suppl 2:66-7. PubMed ID: 5357143
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of oral and intravenous rifampicin administration in the treatment of open pulmonary tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; von Sassen W; Labedzki L; Schwabe HK; Hengstmann J; Eichelbaum M
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():482-4. PubMed ID: 6647280
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rifampicin in treatment of gangliopulmonary forms of initial tuberculosis in young infants and children].
    Dieu JC; Adenis-Lamarre F; Bitar M; Dabbagh M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):320-31. PubMed ID: 5510318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.